151 related articles for article (PubMed ID: 6186360)
1. Interferon: reason for hope.
Warren B
Can Nurse; 1983 Feb; 79(2):15-6. PubMed ID: 6186360
[No Abstract] [Full Text] [Related]
2. Interferon and malignant disease.
Sikora K
Br J Clin Pract; 1986 Oct; 40(10):406-10. PubMed ID: 2443152
[No Abstract] [Full Text] [Related]
3. Interferons and cancer: how the promise is being kept.
Borden EC
Interferon; 1983; 5():43-83. PubMed ID: 6202643
[No Abstract] [Full Text] [Related]
4. Current status of interferon therapy in oncology.
Roth MS; Foon KA
Prog Hematol; 1987; 15():19-38. PubMed ID: 2459731
[No Abstract] [Full Text] [Related]
5. Clinical trials with interferon in Japan.
Imanishi J; Kishida T
Tex Rep Biol Med; 1981-1982; 41():647-52. PubMed ID: 6189229
[No Abstract] [Full Text] [Related]
6. Interferon-new wonder drug or old laboratory curiosity?
Tannock GA
Med J Aust; 1981 Oct; 2(7):352-6. PubMed ID: 6170870
[No Abstract] [Full Text] [Related]
7. Interferons: basic research, clinical studies, and their support.
Friedman RM
Arch Pathol Lab Med; 1982 Jun; 106(6):259-60. PubMed ID: 6178383
[TBL] [Abstract][Full Text] [Related]
8. Interferons and cancer: the end of the beginning or the beginning of the end?
Priestman TJ
Clin Oncol; 1981 Dec; 7(4):271-4. PubMed ID: 6172229
[No Abstract] [Full Text] [Related]
9. Interferons: in pursuit of the promise.
Borden EC
Prog Clin Biol Res; 1983; 132E():287-96. PubMed ID: 6196788
[No Abstract] [Full Text] [Related]
10. [Interferon in cancer--belief, hope and reality].
Strander H; Einhorn S
Lakartidningen; 1980 Aug; 77(32-33):2673-5. PubMed ID: 6161282
[No Abstract] [Full Text] [Related]
11. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
Stone I
Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
[No Abstract] [Full Text] [Related]
12. [Interleukin and interferon--hope or disappointment?].
Vanĕcek K
Cesk Pediatr; 1988 Oct; 43(10):607-9. PubMed ID: 2463110
[No Abstract] [Full Text] [Related]
13. Interferon clinical trials.
Cancer Nurs; 1980 Dec; 3(6):450. PubMed ID: 6159070
[No Abstract] [Full Text] [Related]
14. Prospects for the medical use of interferon in 1984.
Postic B; Arroyo JC
Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270
[No Abstract] [Full Text] [Related]
15. Interferon in Michigan.
Rich J
Mich Med; 1981 Aug; 80(23):402. PubMed ID: 6167843
[No Abstract] [Full Text] [Related]
16. Interferon studies at the Wisconsin Clinical Cancer Center.
Buchanan-Davidson DJ
Wis Med J; 1980 Sep; 79(9):35. PubMed ID: 6158802
[No Abstract] [Full Text] [Related]
17. Interferon: an early evaluation.
McCredie KB; Moore MS
J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226
[No Abstract] [Full Text] [Related]
18. The interferons.
Walsh JP
Med Lab Sci; 1985 Oct; 42(4):346-51. PubMed ID: 2417086
[No Abstract] [Full Text] [Related]
19. Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC).
Oldham RK; Lewko WM; Good RW; Sharp E
In Vivo; 1994; 8(5):653-63. PubMed ID: 7537108
[TBL] [Abstract][Full Text] [Related]
20. The clinical value of interferon--a critical appraisal.
Billiau A; de Somer P; Schellekens H; Weimar W
Neth J Med; 1981; 24(2):72-8. PubMed ID: 6165902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
